Huntington National Bank lowered its stake in shares of Humana Inc (NYSE:HUM) by 7.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,784 shares of the insurance provider’s stock after selling 948 shares during the period. Huntington National Bank’s holdings in Humana were worth $2,836,000 at the end of the most recent quarter.
Other institutional investors have also added to or reduced their stakes in the company. Independent Portfolio Consultants Inc. raised its stake in shares of Humana by 22.1% in the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock worth $125,000 after buying an additional 94 shares during the period. Guardian Life Insurance Co. of America raised its stake in shares of Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock worth $119,000 after buying an additional 4 shares during the period. Point72 Asia Hong Kong Ltd purchased a new stake in shares of Humana during the first quarter worth about $128,000. Westbourne Investment Advisors Inc. purchased a new stake in shares of Humana during the second quarter worth about $205,000. Finally, Hengehold Capital Management LLC purchased a new stake in shares of Humana during the second quarter worth about $209,000. 99.66% of the stock is currently owned by institutional investors.
Humana Inc (NYSE HUM) traded down 0.67% on Friday, hitting $249.99. 840,299 shares of the stock were exchanged. The firm has a market cap of $36.13 billion, a PE ratio of 20.57 and a beta of 0.91. The stock’s 50 day moving average price is $239.62 and its 200 day moving average price is $222.88. Humana Inc has a 52-week low of $163.50 and a 52-week high of $255.27.
Humana (NYSE:HUM) last issued its earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, topping the consensus estimate of $3.08 by $0.41. The company had revenue of $13.53 billion during the quarter, compared to analyst estimates of $13.61 billion. Humana had a return on equity of 24.61% and a net margin of 4.80%. During the same quarter last year, the firm earned $2.30 EPS. Equities research analysts forecast that Humana Inc will post $11.55 earnings per share for the current year.
TRADEMARK VIOLATION NOTICE: “Huntington National Bank Cuts Stake in Humana Inc (HUM)” was originally posted by Stock Observer and is the sole property of of Stock Observer. If you are reading this piece on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The original version of this piece can be accessed at https://www.thestockobserver.com/2017/08/12/huntington-national-bank-has-2-84-million-stake-in-humana-inc-hum-updated-updated.html.
A number of equities research analysts have recently weighed in on HUM shares. UBS AG reaffirmed a “neutral” rating and set a $250.00 target price (up previously from $237.00) on shares of Humana in a research note on Wednesday. BidaskClub raised shares of Humana from a “sell” rating to a “hold” rating in a research report on Thursday. Cantor Fitzgerald reissued a “neutral” rating and set a $223.00 price target (up from $200.00) on shares of Humana in a research report on Thursday, August 3rd. Jefferies Group LLC reissued a “hold” rating and set a $257.00 price target on shares of Humana in a research report on Friday, August 4th. Finally, Deutsche Bank AG lifted their target price on shares of Humana from $234.00 to $243.00 and gave the stock a “hold” rating in a report on Monday, August 7th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have issued a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $243.65.
In other Humana news, SVP Brian P. Leclaire sold 4,971 shares of Humana stock in a transaction on Wednesday, June 28th. The stock was sold at an average price of $240.00, for a total transaction of $1,193,040.00. Following the sale, the senior vice president now owns 14,258 shares of the company’s stock, valued at approximately $3,421,920. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Heidi S. Margulis sold 1,500 shares of Humana stock in a transaction on Friday, May 26th. The shares were sold at an average price of $231.96, for a total value of $347,940.00. Following the sale, the vice president now directly owns 8,150 shares in the company, valued at approximately $1,890,474. The disclosure for this sale can be found here. 0.80% of the stock is currently owned by company insiders.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc and related companies with MarketBeat.com's FREE daily email newsletter.